HCM — HUTCHMED (China) Income Statement
0.000.00%
Last trade - 00:00
- $3.52bn
- $2.81bn
- $838.00m
- 51
- 22
- 71
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 205 | 228 | 356 | 426 | 838 |
Cost of Revenue | |||||
Gross Profit | 44.7 | 39.5 | 97.9 | 115 | 454 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 351 | 425 | 563 | 834 | 825 |
Operating Profit | -146 | -197 | -207 | -408 | 12.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -100 | -111 | -155 | -361 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | -104 | -116 | -167 | -360 | 101 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -106 | -126 | -195 | -361 | 101 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -106 | -126 | -195 | -361 | 101 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.159 | -0.18 | -0.246 | -0.426 | 0.122 |